Table: RaQualia Pharma -2024 parent results
Feb 14 (Reuters)-
RaQualia Pharma Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2024 Dec 31, 2023 Dec 31, 2025 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 2.50 1.64
(+52.0 pct) (-38.7 pct)
Operating 322 mln loss 478 mln
Recurring 196 mln loss 444 mln
Net 56 mln loss 431 mln
EPS 2.60 yen loss 19.95 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - RaQualia Pharma Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T